Home > Boards > US Listed > Biotechs > Geron Corp. (GERN)

BioTime is now Lineage Cell Therapeutics, Inc. LCTX

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Liquid_Bull Member Profile
 
Followed By 3
Posts 790
Boards Moderated 0
Alias Born 01/10/10
160x600 placeholder
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 11/18/2021 4:30:00 PM
Geron to Present at the Stifel 2021 Virtual Healthcare Conference Business Wire - 11/12/2021 7:30:00 AM
Geron slips despite quarterly EPS, revenue beat Seeking Alpha - 11/10/2021 2:01:37 PM
Geron EPS beats by $0.01, beats on revenue Seeking Alpha - 11/10/2021 8:46:19 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/10/2021 6:04:03 AM
Geron Announces Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting Business Wire - 11/4/2021 9:12:00 AM
Baird initiates Geron with an outperform on outlook for lead candidate imetelstat Seeking Alpha - 11/2/2021 8:12:34 AM
Geron Enters New Innovative Licensing and Access Pathway in the United Kingdom for Imetelstat Business Wire - 10/25/2021 4:30:00 PM
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 10/21/2021 4:30:00 PM
Geron Announces Completion of Patient Enrollment in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes Business Wire - 10/18/2021 7:30:00 AM
Geron to Host a Virtual Investor Event in November Business Wire - 10/15/2021 4:05:00 PM
Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology Business Wire - 10/11/2021 4:30:00 PM
Understanding Changes in Geron’s Risk Factors TipRanks - 10/5/2021 6:10:08 AM
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 9/16/2021 4:30:00 PM
Geron Announces September Investor Conference Presentation Webcasts Business Wire - 9/1/2021 4:30:00 PM
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 8/19/2021 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/16/2021 4:24:52 PM
Geron Corporation Reports Greater Than 90% Enrollment in IMerge Phase 3 and Expected Top-Line Results Accelerated to First Quarter of 2023 Business Wire - 8/16/2021 4:06:00 PM
Geron to Announce Second Quarter 2021 Financial Results on August 16, 2021 Business Wire - 8/5/2021 4:30:00 PM
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 7/22/2021 4:45:00 PM
Geron shares shoot up 51% on phase 2 data for myelofibrosis candidate Seeking Alpha - 6/18/2021 12:31:44 PM
Geron surges after publication of IMbark Phase 2 data Seeking Alpha - 6/17/2021 11:22:50 PM
Geron Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology Business Wire - 6/17/2021 4:30:00 PM
Geron Reports Two Presentations at Virtual European Hematology Association Annual Congress Business Wire - 6/14/2021 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2021 5:21:23 PM
Liquid_Bull   Tuesday, 10/15/19 12:15:57 PM
Re: Alliebaby42 post# 6803
Post # of 7132 
BioTime is now Lineage Cell Therapeutics, Inc. LCTX

I have owned shares in and have been following GERN for years as well and I would hate to not own any at this point in time.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences